ClinicalTrials.gov
ClinicalTrials.gov Menu

Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure (GENETIC-AF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01970501
Recruitment Status : Completed
First Posted : October 28, 2013
Last Update Posted : January 9, 2018
Sponsor:
Collaborator:
Medtronic
Information provided by (Responsible Party):
ARCA Biopharma, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 28, 2017
  Actual Study Completion Date : December 28, 2017
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):